About the solution
In 1992, Tal entered a genetic study and found out that, as many other Marfan Syndrome patients, his ascending aorta was failing to recover after each blood-flow and was gradually enlarging over time.
In 2000, during a regular check-up, he was told to consider pre-emptive surgery. However, traditional surgery is lengthy and complex as it replaces the ascending aorta by an artificial graft. Also, to prevent blood clots forming on the replaced vessel, the patient has to take anticoagulant drugs for the rest of his/her life. Tal did not like the scenario for his future, so he started to think of alternatives.
Being a process engineer, he compared his enlarged aorta to a plumbing problem, so he thought that he had to create something that would act like an insulation tape, that could be wrapped around the outside of the a aorta. The same thing that everyone does when a hosepipe is bulging. After a lot of CAD models, together with his doctor, they developed the final prototype, the ExoVasc®. The device was placed on Tal during a two-hour surgery, in 2004.
“To build technical and commercial teams, raise the finance, run the project AND volunteer to be the first patient was not so easy, particularly as I was trying to operate as a rational project manager when I knew the outcome of the project could have such a profound impact on my future health”, he explained.
The ExoVasc®, Personalised External Aortic Root Support, is a custom-made external support made to exactly match the patient’s aorta. This is placed around the ascending aorta, which remains intact. Since the vessel and the valve remain intact, the surgery is more straightforward and there is no need for the patient to take anticoagulant drugs.
The engineer comercializes this product through his company - Exstent.
Tal was awarded with the Patient Innovation award in 2015.
This solution shall not include mention to the use of drugs, chemicals or biologicals (including food); invasive devices; offensive, commercial or inherently dangerous content. This solution was not medically validated. Proceed with caution! If you have any doubts, please consult with a health professional.
• Tue, 03/26/2019 - 07:05
Patient health is key. what a healthy piece. https://www.smilestreetdentistry.com
• Tue, 06/04/2019 - 13:55
Personalized external aortic root support (PEARS) is an emerging technology. It is a pre-emptive operation to halt aortic root expansion and maintain aortic valve function in Marfan syndrome and is also applicable to aortic root aneurysms of other aetiologies. This can really help those who need it!
Chris | https://www.michelsscreenandfence.com/
• Tue, 06/25/2019 - 17:20
Because the ExoVasc® supports the aorta, the patient can be sure their aorta will not continue to expand. Because the patient does not need to take anticoagulant drugs, they need not live in fear of excessive bleeding. The reinforced aorta reverts to a structure similar to normal, the patient’s own valve is supported and further surgery is unlikely to be necessary.
Manuel | https://www.charlottefenceinstallation.com
• Tue, 06/25/2019 - 18:22
Humans are so smart to come up to an output like this! Thanks for posting this, as this will serve an inspiration for someone and everyone who needs this today and in the future. https://www.us-mailing-change-of-address.com/
• Wed, 07/10/2019 - 17:34
This is a piece of advice for our health , very nice technology for same cases. | http://discoverziehler.com
• Thu, 07/11/2019 - 22:51
The information and facts talked about within the post are a few of the most effective obtainable. chess of blades
• Tue, 08/13/2019 - 03:24
Congratulations Tal! For the Patient Innovation award. I guess a patient doesn't have to take low interest personal loans for this.
• Wed, 08/28/2019 - 10:06
Congratulations on your award!
• Mon, 09/02/2019 - 17:24
• Thu, 09/05/2019 - 12:14
Advance technology for higher solution! Keep it up guys!
• Tue, 09/10/2019 - 01:28
That is so amazing that this man Tal Golesworthy developed his own solution for Marfan Syndrome, which now certainly helps thousands.
- Matt | Solar Company Tempe
This work is being financed by the FCT project with the reference PTDC/EGE-OGE/7995/2020
Copyright © 2022 Patient Innovation.
Powered by Orange Bird